Fixed‐dose combination aclidinium/formoterol vs formoterol
Lung function · patients with chronic obstructive pulmonary disease
1 finding from 1 review
- Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD) 2018 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 2411 participantsHigh